“Homozygous, and compound heterozygous mutation in 3 Turkish family with Jervell and Lange-Nielsen syndrome: case reports”
Open Access
- 16 October 2017
- journal article
- case report
- Published by Springer Nature in BMC Medical Genetics
- Vol. 18 (1) , 114
Abstract
Jervell and Lange-Nielsen syndrome (JLNS) isa recessive model of long QT syndrome which might also be related to possible hearing loss. Although the syndrome has been demonstrated to be originated from homozygous or compound heterozygous mutations in either the KCNQ1 or KCNE1 genes, additional mutations in other genetic loci should be considered, particularly in malignant course patients. Three patients were admitted into hospital due to recurrent seizures/syncope, intrauterine and postnatal bradycardia respectively; moreover all three patients had congenital sensorineural hearing-loss. Their electrocardiograms showed markedly prolonged QT interval. Implantable defibrillator was implanted and left cardiac sympathetic denervation was performed due to the progressive disease in case 1. She had countless ventricular fibrillation and appropriate shock while using an implantable defibrillator. The DNA sequencing analysis of the KCNQ1 gene disclosed a homozygous c.728G > A (p.Arg243His) missense mutation in case1. Further targeted next generation sequencing of cardiac panel comprising 68 gene revealed a heterozygous c.1346 T > G (p.Ile449Arg) variant in RYR2 gene and a heterozygous c.809G > A (p.Cys270Tyr) variant in NKX2–5 gene in the same patient. Additional gene alterations in RYR2 and NKX2–5 genes were thought to be responsible for progressive and malignant course of the disease. As a result of DNA sequencing analysis of KCNQ1 and KCNE1 genes, a compound heterozygosity for two mutations had been detected in KCNQ1 gene in case 2: a maternally derived c.477 + 1G > A splice site mutation and a paternally derived c.520C > T (p.Arg174Cys) missense mutation. Sanger sequencing of KCNQ1 and KCNE1 genes displayed a homozygous c.1097G > A (p.Arg366Gln) mutation in KCNQ1 gene in case 3. β-blocker therapy was initiated to all the index subjects. Three families of JLNS who presented with long QT and deafness and who carry homozygous, or compound heterozygous mutation in KCNQ1 gene were presented in this report. It was emphasized that broad targeted cardiac panels may be useful to predict the outcome especially in patients with unexplained phenotype-genotype correlation. Clinical presentations and molecular findings will be discussed further to clarify the phenotype genotype associations.Keywords
This publication has 29 references indexed in Scilit:
- Comprehensive genetic testing can save lives in hereditary hearing lossClinical Genetics, 2014
- Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION® long QT syndrome genetic testHeart Rhythm, 2009
- The Jervell and Lange-Nielsen SyndromeCirculation, 2006
- In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heartCardiovascular Research, 2005
- Implantable Cardioverter Defibrillator Therapy in Children with Long QT SyndromePediatric Cardiology, 2004
- Spectrum of Mutations in Long-QT Syndrome GenesCirculation, 2000
- Novel mutations in KvLQT1 that affect Iks activation through interactions with IskCardiovascular Research, 2000
- Long QT Syndrome-associated Mutations in the S4-S5 Linker of KvLQT1 Potassium Channels Modify Gating and Interaction with minK SubunitsJournal of Biological Chemistry, 1999
- Novel KCNQ1 and HERG missense mutations in Dutch long-QT familiesHuman Mutation, 1999
- KCNE1 mutations cause Jervell and Lange-Nielsen syndromeNature Genetics, 1997